These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 4051519

  • 1. [Antitumor activities of orally administered 4-carbamoylimidazolium-5-olate (SM-108)].
    Nakamura M, Fukui M, Morisada S, Inaba M, Tsukagoshi S, Sakurai Y.
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2030-6. PubMed ID: 4051519
    [Abstract] [Full Text] [Related]

  • 2. Optimal treatment schedule and antitumor spectrum of 4-carbamoylimidazolium 5-olate (SM-108) in murine tumors.
    Yoshida N, Nakamura M, Fukui M, Morisada S, Ogino S, Inaba M, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1983 Dec; 43(12 Pt 1):5851-6. PubMed ID: 6640536
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activities of newly synthesized 5-carbamoyl-1 H-imidazol-4yl 1-adamantanecarboxylate and 5-carbamoyl-1H-imidazol-4yl piperonylate.
    Yoshida N, Kiyohara T, Fukui M, Atsumi T, Ogino S, Inaba M, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1980 Oct; 40(10):3810-4. PubMed ID: 7438064
    [Abstract] [Full Text] [Related]

  • 4. [The antitumor activity of intraperitoneally- or orally-administered etoposide in animals and its administration-schedule dependency].
    Okamoto K, Nishikawa K, Seki T, Shibasaki C, Uchida T, Takahashi K.
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2331-7. PubMed ID: 4073928
    [Abstract] [Full Text] [Related]

  • 5. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N, Kraus-Berthier L, Saint-Dizier D, Rouillon MH, Jan M, Burbridge M, Visalli M, Bisagni E, Pierré A, Atassi G.
    Cancer Chemother Pharmacol; 1996 Dec; 38(6):513-21. PubMed ID: 8823492
    [Abstract] [Full Text] [Related]

  • 6. [Antitumor activities of orally administered 7-con-0-methylnogarol (TUT-7)].
    Sugimoto Y, Matsuo K, Takeda S, Yamada Y, Tsukagoshi S.
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):353-8. PubMed ID: 2138003
    [Abstract] [Full Text] [Related]

  • 7. Antitumor activity of 1-alkoxycarbonylalkylcarbamoyl-5-fluorouracil derivatives by oral administration.
    Iigo M, Hoshi A, Inomata M, Ando N, Kuretani K.
    J Pharmacobiodyn; 1981 Mar; 4(3):203-10. PubMed ID: 7252769
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K, Tsuruo T, Naganuma K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034
    [Abstract] [Full Text] [Related]

  • 9. In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor models.
    Zylicz Z, Wagener DJ, van Rennes H, van der Kleijn E, Lelieveld P, van den Broek LA, Ottenheijm HC.
    Invest New Drugs; 1988 Dec; 6(4):285-92. PubMed ID: 3229941
    [Abstract] [Full Text] [Related]

  • 10. Selective reduction of intracellular guanosine 5'-triphosphate pool by 4-carbamoylimidazolium 5-olate in murine tumor cells.
    Fukui M, Inaba M, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1986 Jan; 46(1):43-6. PubMed ID: 2866032
    [Abstract] [Full Text] [Related]

  • 11. Antitumor activity of a crude fucoidan fraction prepared from the roots of kelp (Laminaria species).
    Chida K, Yamamoto I.
    Kitasato Arch Exp Med; 1987 Jun; 60(1-2):33-9. PubMed ID: 3669501
    [No Abstract] [Full Text] [Related]

  • 12. Antitumor activity of two novel low immunosuppressive fluoropyrimidines UK-21 and UK-25.
    Sakamoto O, Mori H, Kitaichi K, Koda A, Kato T.
    Jpn J Pharmacol; 1992 Aug; 59(4):469-76. PubMed ID: 1434142
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate.
    Inaba M, Fukui M, Yoshida N, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1982 Mar; 42(3):1103-6. PubMed ID: 6277474
    [Abstract] [Full Text] [Related]

  • 15. [Studies on the antitumor activity of mitoxantrone in animals].
    Wang CJ, Liu YL, Li YQ, Luo DY, Xu PL, Xiao SH, Liao YF, He L.
    Hua Xi Yi Ke Da Xue Xue Bao; 1987 Sep; 18(3):235-7. PubMed ID: 3679174
    [No Abstract] [Full Text] [Related]

  • 16. [Comparative studies on the antitumor activity of the fluorinated pyrimidines 5'-DFUR, tegafur, UFT and FUra on various murine tumors].
    Miwa M, Eda H, Fukuda H, Fujimoto K, Ishitsuka H.
    Gan To Kagaku Ryoho; 1988 May; 15(5):1755-63. PubMed ID: 2967051
    [Abstract] [Full Text] [Related]

  • 17. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
    Ishizeki S, Ohtsuka M, Irinoda K, Kukita K, Nagaoka K, Nakashima T.
    J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activities of (2"R)-4'-O-tetrahydropyranyl-adriamycin (THP) and its combination with other antitumor agents on murine tumors.
    Matsushita Y, Kumagai H, Yoshimoto A, Tone H, Ishikura T, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1985 Oct; 38(10):1408-19. PubMed ID: 4066493
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of antitumor activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine in murine tumors.
    Furusawa S, Mian AM.
    Cancer Treat Rep; 1987 May; 71(5):441-6. PubMed ID: 3567967
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.